193 related articles for article (PubMed ID: 24289619)
1. Matrix metalloproteinase-2 (-1306 c>t) promoter polymorphism and risk of colorectal cancer in the Saudi population.
Saeed HM; Alanazi MS; Parine NR; Shaik J; Semlali A; Alharbi O; Azzam N; Aljebreen A; Almadi M; Shalaby MA
Asian Pac J Cancer Prev; 2013; 14(10):6025-30. PubMed ID: 24289619
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 C(-1306)T promoter polymorphism and breast cancer risk in the Saudi population.
Saeed HM; Alanazi MS; Alshahrani O; Parine NR; Alabdulkarim HA; Shalaby MA
Acta Biochim Pol; 2013; 60(3):405-9. PubMed ID: 24051440
[TBL] [Abstract][Full Text] [Related]
3. Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the Saudi population.
Shalaby MA; Nounou HA; Ms A; O A; Azzam N; Saeed HM
Asian Pac J Cancer Prev; 2014; 15(12):4989-94. PubMed ID: 24998576
[TBL] [Abstract][Full Text] [Related]
4. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
5. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Hettiaratchi A; Hawkins NJ; McKenzie G; Ward RL; Hunt JE; Wakefield D; Di Girolamo N
Br J Cancer; 2007 Mar; 96(5):783-92. PubMed ID: 17311017
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
7. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
8. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
9. The Contribution of
Yueh TC; Wu CN; Hung YW; Chang WS; Fu CK; Pei JS; Wu MH; Lai YL; Lee YM; Yen ST; Li HT; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(3):207-212. PubMed ID: 29695403
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
Rahimi Z; Yari K; Rahimi Z
Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
[TBL] [Abstract][Full Text] [Related]
11. The Effect of
Alhadheq AM; Purusottapatnam Shaik J; Alamri A; Aljebreen AM; Alharbi O; Almadi MA; Alhadeq F; Azzam NA; Semlali A; Alanazi M; Bazzi MD; Reddy Parine N
Dis Markers; 2016; 2016():8289293. PubMed ID: 27746584
[No Abstract] [Full Text] [Related]
12. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.
Matsumura S; Oue N; Kitadai Y; Chayama K; Yoshida K; Yamaguchi Y; Toge T; Imai K; Nakachi K; Yasui W
J Cancer Res Clin Oncol; 2004 May; 130(5):259-65. PubMed ID: 14986114
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population.
Saeed HM; Alanazi MS; Nounou HA; Salaby MA; Semlali A; Azzam N; Aljebreen A; Alharby O; Parine NR; Shaik J; Arafaha M
Asian Pac J Cancer Prev; 2013; 14(6):3761-8. PubMed ID: 23886179
[TBL] [Abstract][Full Text] [Related]
14. MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not.
Langers AM; Sier CF; Hawinkels LJ; Kubben FJ; van Duijn W; van der Reijden JJ; Lamers CB; Hommes DW; Verspaget HW
Br J Cancer; 2008 Jun; 98(11):1820-3. PubMed ID: 18506186
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
16. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Chaudhary AK; Pandya S; Mehrotra R; Singh M; Singh M
Biomarkers; 2011 Nov; 16(7):577-86. PubMed ID: 21958210
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben NĂ©jima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
18. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population.
Delgado-Enciso I; Cepeda-Lopez FR; Monrroy-Guizar EA; Bautista-Lam JR; Andrade-Soto M; Jonguitud-Olguin G; Rodriguez-Hernandez A; Anaya-Ventura A; Baltazar-Rodriguez LM; Orozco-Ruiz M; Soriano-Hernandez AD; Rodriguez-Sanchez IP; Lugo-Trampe A; Espinoza-Gomez F; Michel-Peregrina ML
Gynecol Obstet Invest; 2008; 65(1):68-72. PubMed ID: 17851253
[TBL] [Abstract][Full Text] [Related]
20. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers.
Singh K; Agrawal NK; Gupta SK; Singh K
Int J Low Extrem Wounds; 2013 Sep; 12(3):199-204. PubMed ID: 24043671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]